Currently, more than 1000 customers are utilizing the original Tracker software for all three verticals which will be phased out next year. During the transition period, MJ Freeway will be assisting those customers with training on the software features and matching them with an assigned customer care specialist who can help migrate data from Trackers to MJ Platform.
“When we first developed the original software, we just wanted to help growers, manufacturers, and dispensaries effectively run sustainable businesses and show people the importance of cannabis,” said COO, Jessica Billingsley. “Although we’ve experienced our share of growing pains, we are committed to continuing to do just that. Our vision is to help more cannabis companies serve more customers, increase their presence in the industry, and maximize revenue growth. We know that the enhancements we’ve made to MJ Platform will outperform anything else on the market.”
About MJ Freeway:
MJ Freeway® is the industry-leading software, consulting, and data solution for cannabis businesses, processing $5B in cannabis sales transactions and serving clients in every regulated market in the United States, Canada, Europe, and Australia. Founded in 2010 and designed and built specifically for cannabis businesses, MJ Freeway’s technology includes a patented seed to sale supply chain ERP Platform which leverages sophisticated business intelligence insights. MJ Freeway’s Leaf Data Systems software solution enables governments to track cannabis, prevent diversion, and ensure patient, public, and product safety. MJ Freeway also offers a complete suite of consulting services for new and existing cannabis businesses.
This news is published on the Investorideas.com Newswire – a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 – all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Source: New feed